Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013

Influenza and other Respiratory Viruses

Volumn 9, Issue 3, 2015, Pages 143-150

  McAnerney, Johanna M ^a   Walaza, Sibongile ^a   Cohen, Adam L ^b   Tempia, Stefano ^a,b   Buys, Amelia ^a   Venter, Marietjie ^a   Blumberg, Lucille ^a   Duque, Jazmin ^b,c   Cohen, Cheryl ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

Attitudes; Influenza like illness; Knowledge; Practices; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PHYSICIAN ATTITUDE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEASONAL VARIATION; SOUTH AFRICA; ATTITUDE TO HEALTH; CASE CONTROL STUDY; GENETIC DRIFT; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN; MIDDLE AGED; PRESCHOOL CHILD; SEASON; SENTINEL SURVEILLANCE; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC DRIFT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SEASONS; SENTINEL SURVEILLANCE; SOUTH AFRICA; TIME FACTORS; VACCINATION; YOUNG ADULT;

EID: 84928189084     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12305     Document Type: Article

References (26)

1. Wilschut J, McElhaney J, Palache A (eds). Influenza, 49-95, 2nd ed. Elsevier: Mosby, 2006.
2. Schoub B. Recommendations pertaining to the use of viral vaccines: influenza 2013. S Afr Med J 2013; 103:80.
3. Ramkrishna W, Hlungwani P, Furumele T, Benson F (eds). Coverage of high risk groups for influenza vaccination in South Africa, 2011-2013 influenza seasons. Options for the control of influenza VIII; 2013; Cape Town South Africa.
4. Skowronski DM, Janjua NZ, De Serres G et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012; 55:332-342.
5. Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS ONE 2009; 4:e5079.
6. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28:7381-7388.
7. McAnerney JM, Cohen C, Moyes J et al. Twenty-five years of outpatient influenza surveillance in South Africa, 1984-2008. J Infect Dis 2012; 206(Suppl 1):S153-S158.
8. Pretorius MA, Madhi SA, Cohen C et al. Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalised with severe acute respiratory illness-South Africa, 2009-2010. J Infect Dis 2012; 206(Suppl 1):S159-S165.
9. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31:2165-2168.
10. De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 2013; 18:20585.
11. McMenamin J, Andrews N, Robertson C et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill 2013; 18:20393.
12. Castilla J, Martinez-Baz I, Martinez-Artola V et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013; 18:20388.
13. Pebody R, Andrews N, McMenamin J et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013; 18:20851.
14. Andrews N, McMenamin J, Durnall H et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill 2014; 19:20585.
15. Rondy M, Puig-Barbera J, Launay O et al. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study. PLoS ONE 2013; 8:e59681.
16. Kissling E, Valenciano M, Larrauri A. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013; 18:20390.
17. Sullivan SG, Kelly H. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. Euro Surveill 2013; 18:20605.
18. Turner N, Pierse N, Bissielo A et al. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Euro Surveill 2014; 19:20884.
19. Ntshoe GM, McAnerney JM, Tempia S et al. Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009. PLoS ONE 2014; 9:e94681.
20. Cohen C, Moyes J, Tempia S et al. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis 2013; 19:1766-1774.
21. Ohmit SE, Petrie JG, Malosh RE et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56:1363-1369.
22. Cheng AC, Holmes M, Irving LB et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS ONE 2013; 8:e68760.
23. Luna J, Gattas VL. Effectiveness of the Brazilian influenza vaccination policy, a systematic review. Rev Inst Med Trop 2010; 52:175-181.
24. Valenciano M, Kissling E, Team IMC-CS. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill 2013; 18:3.
25. Mihigo R, Torrealba CV, Coninx K et al. 2009 pandemic influenza a virus subtype H1N1 vaccination in Africa - successes and challenges. J Infect Dis 2012;206:S22-S28.
26. Oria PA, Matini W, Nelligan I et al. Are Kenyan healthcare workers willing to receive the pandemic influenza vaccine? Results from a cross-sectional survey of healthcare workers in Kenya about knowledge, attitudes and practices concerning infection with and vaccination against 2009 pandemic influenza A (H1N1), 2010. Vaccine 2011; 29:3617-3622.